Andrew Derodra of Tate & Lyle Plc has been named chief financial officer and executive director of Skyepharma Plc to fill the position formerly held by Peter Grant, the current chief executive. Mr Derodra has been group vice president finance and Control at Tate & Lyle since 2011. He has worked for 23 years in senior finance roles at five of the UK’s largest companies including British Airways Plc and Reed Elsevier Plc.
Skyepharma announced the appointment on 22 August 2013.
Copyright 2013 Evernow Publishing Ltd